Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -192.41x is 26% below its 5-year average of -152.85x, near the low end of its 5-year range (-331.05x–439.05x).
24.37% above its 12-month average of -254.41x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -331.05x.
INTEREST COVERAGE RATIO
-192.41x
INTEREST COVERAGE RATIO AVG TTM
-254.41x
INTEREST COVERAGE RATIO AVG 3Y
-156.94x
INTEREST COVERAGE RATIO AVG 5Y
-152.85x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+24.37%
CURRENT VS 3Y AVG
-22.60%
CURRENT VS 5Y AVG
-25.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-4448.70%
vs the sector median at left
Immatics N.V.
Market Cap
$1.01B
Interest Coverage Ratio
-192.41x
TTM Avg
-254.41x
3Y Avg
-156.94x
5Y Avg
-152.85x
Market Cap
$987.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.01B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Interest Coverage Ratio
0.79x
TTM Avg
0.59x
3Y Avg
2.04x
5Y Avg
2.37x
Market Cap
$1.00B
Interest Coverage Ratio
-8.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$999.08M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Interest Coverage Ratio
0.23x
TTM Avg
0.32x
3Y Avg
0.27x
5Y Avg
0.27x
Market Cap
$986.19M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immatics N.V. (IMTX) | $1.01B | -192.41x | -254.41x | -156.94x | -152.85x |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $987.02M | N/A | N/A | N/A | N/A |
| Janux Therapeutics, Inc. (JANX)vs › | $1.01B | N/A | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.00B | 0.79x | 0.59x | 2.04x | 2.37x |
| MeiraGTx Holdings plc (MGTX)vs › | $1.00B | -8.69x | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $999.08M | N/A | N/A | N/A | N/A |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | 0.23x | 0.32x | 0.27x | 0.27x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $986.19M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.04B | -13.34x | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $971.43M | N/A | N/A | N/A | N/A |
Interest Coverage
-192.4x
Debt/Equity
0.04
Current Ratio
7.54
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -331.05x |
| 2026-03-31 | -311.62x |
| 2025-12-31 | -175.14x |
| 2025-09-30 | -236.51x |
| 2025-06-30 | -217.73x |
| 2025-03-31 | -142.06x |
| 2024-12-31 | 3.89x |
| 2024-09-30 | 2.19x |
| 2024-06-30 | -117.54x |
| 2024-03-31 | -69.43x |
| 2023-12-31 | -131.35x |
| 2022-06-30 | -54.26x |
| 2022-03-31 | 439.05x |
| 2021-12-31 | -120.75x |
| 2021-09-30 | -161.98x |
| 2021-06-30 | -229.37x |
| 2021-03-31 | -425.68x |
| 2020-12-31 | -62.01x |
| 2020-06-30 | -725.89x |
| 2019-12-31 | -383.81x |
| 2019-09-30 | -180.37x |
| 2019-06-30 | -13.66x |
| 2019-03-31 | -83.49x |
| 2018-12-31 | -2150.56x |
| 2018-09-30 | -2150.56x |
| 2018-06-30 | -2150.56x |
| 2018-03-31 | -2150.56x |
